We are live on ! Find out more
BFM

Boothbay Fund Management Portfolio holdings

AUM $7.71B
1-Year Est. Return 106.31%
This Fund
S&P 500
This Quarter Est. Return
+42.64%
1 Year Est. Return
+106.31%
3 Year Est. Return
+266.76%
5 Year Est. Return
+310.53%
10 Year Est. Return
+1,580.35%
AUM
$1.46B
AUM Growth
+$256M
Cap. Flow
+$4.95B
Cap. Flow %
338.44%
Top 10 Hldgs %
14.04%
Holding
1,230
New
412
Increased
195
Reduced
230
Closed
293

Sector Composition

Rank Sector Weight
1 Technology 11.56%
2 Consumer Discretionary 8.68%
3 Healthcare 7.6%
4 Communication Services 6.73%
5 Industrials 4.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACN icon
926
Accenture
ACN
$102B
-1,248
Closed -$204K
ADNT icon
927
Adient
ADNT
$1.65B
-14,400
Closed -$131K
ADPT icon
928
Adaptive Biotechnologies
ADPT
$3.59B
-7,400
Closed -$206K
AEP icon
929
American Electric Power
AEP
$69.6B
-3,100
Closed -$248K
AFL icon
930
Aflac
AFL
$64.9B
-9,400
Closed -$322K
ALE
931
DELISTED
Allete
ALE
-3,759
Closed -$228K
ALNY icon
932
CALL
Alnylam Pharmaceuticals
ALNY
$27.5B
-310
Closed -$3.37M
ALNY icon
933
PUT
Alnylam Pharmaceuticals
ALNY
$27.5B
-90
Closed -$980K
AMCX icon
934
CALL
AMC Global Media
AMCX
$492M
-84
Closed -$204K
AMD icon
935
CALL
Advanced Micro Devices
AMD
$776B
-579
Closed -$2.63M
AMLP icon
936
Alerian MLP ETF
AMLP
$13B
-10,576
Closed -$182K
AMPY icon
937
Amplify Energy
AMPY
$161M
-14,000
Closed -$8K
APLS
938
DELISTED
Apellis Pharmaceuticals
APLS
-9,448
Closed -$253K
APLS
939
PUT
DELISTED
Apellis Pharmaceuticals
APLS
-118
Closed -$316K
ARGX icon
940
CALL
argenx
ARGX
$53.4B
-101
Closed -$1.33M
ARGX icon
941
argenx
ARGX
$53.4B
-4,972
Closed -$883K
ASIX icon
942
AdvanSix
ASIX
$541M
-13,000
Closed -$124K
ASIX icon
943
PUT
AdvanSix
ASIX
$541M
-260
Closed -$248K
ASMB icon
944
PUT
Assembly Biosciences
ASMB
$498M
-21
Closed -$374K
ASND icon
945
PUT
Ascendis Pharma A/S
ASND
$16B
-94
Closed -$1.06M
ATEN icon
946
A10 Networks
ATEN
$2.13B
-37,099
Closed -$230K
OPTU
947
Optimum Communications Inc
OPTU
$298M
-9,100
Closed -$203K
AVDL
948
CALL
DELISTED
Avadel Pharmaceuticals
AVDL
-831
Closed -$660K
AVTR icon
949
Avantor
AVTR
$9.32B
-22,303
Closed -$279K
AXTI icon
950
AXT Inc
AXTI
$3.95B
-71,816
Closed -$231K

Similar funds

Boothbay Fund Management's Q2 2020 Portfolio in Review

As of Q2 2020, Boothbay Fund Management held 1,230 positions worth $1.46B, up 21% from $1.21B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Boothbay Fund Management deployed $4.95B of net new capital in Q2 2020, opening 412 new positions and adding to 195 existing holdings. Its largest new stake was Tesla: 90,556,950 shares worth $25.6M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Sprott Physical Platinum and Palladium Trust, an estimated $11.4M trimmed.

  • Boothbay Fund Management's largest Q2 2020 buy was Tesla: 90,556,950 shares worth $25.6M.
  • Boothbay Fund Management added most to Alphabet (Google) Class C in Q2 2020, an estimated $27.1M increase.
  • Boothbay Fund Management's biggest Q2 2020 reduction was Sprott Physical Platinum and Palladium Trust, cutting an estimated $11.4M.
  • Boothbay Fund Management fully exited Allergan plc in Q2 2020, selling an estimated $46.4M.
  • Boothbay Fund Management's ten largest holdings make up 14% of its $1.46B portfolio in Q2 2020.
  • Boothbay Fund Management opened 412 new positions and closed 293 in Q2 2020.
  • Boothbay Fund Management's portfolio value rose 21% quarter-over-quarter to $1.46B.

Based on Boothbay Fund Management's 13F filing for Q2 2020, filed 14 Aug 2020.